BCHE and Alzheimer disease: However, despite our limited understanding of the mechanism of PSCI, due to the overlapping neuropathological mechanisms, drugs approved by the FDA for AD, such as donepezil, cholinesterase inhibitors, and non-competitive N-methyl-D aspartic acid receptor antagonists, are effectively administered to treat PSCI and VCI (Wang et al., 2021).